Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Works of Aiping Zhou being referenced
Phase 1 study of WNT pathway Porcupine inhibitor CGX1321 and phase 1b study of CGX1321 + pembrolizumab (pembro) in patients (pts) with advanced gastrointestinal (GI) tumors.
2023
Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin‐specific peptidase 9, X‐linked in oral squamous cell carcinoma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aiping Zhou | 361 | 97 | 110 | 191 | 50 | 619 | |
| Hiroto Matsui | 371 | 135 | 133 | 160 | 64 | 682 | |
| Eun Shin | 266 | 105 | 110 | 155 | 42 | 569 | |
| Patricia Roxburgh | 467 | 41 | 73 | 281 | 47 | 719 | |
| Shuangyi Ren | 171 | 91 | 106 | 293 | 59 | 635 | |
| Yunfei Zuo | 174 | 64 | 79 | 325 | 37 | 618 | |
| Yoshiaki Maru | 335 | 95 | 61 | 247 | 24 | 675 | |
| Pei Shen | 167 | 56 | 55 | 177 | 30 | 588 | |
| Cheng Fu | 164 | 169 | 108 | 190 | 55 | 709 | |
| Ying Dai | 169 | 63 | 105 | 238 | 25 | 549 | |
| Jane Preuss Hasselby | 410 | 217 | 112 | 174 | 58 | 683 |
All Works
Login with ORCID to disown or claim papers
Loading papers...